alexa Development of a simple HPLC method for separation of doxycycline and its degradation products.
Pharmaceutical Sciences

Pharmaceutical Sciences

Journal of Bioequivalence & Bioavailability

Author(s): Sklason S, Inglfsson E, Kristmundsdttir T

Abstract Share this page

Abstract A simple HPLC method for the separation of doxycycline and its degradation products 6-epidoxycycline and metacycline was developed. Numerous HPLC conditions were tested for the qualitative determination of doxycycline and its degradation products. The best result was achieved by using Phenomenex Luna 5 microm C(8) 250 x 4.6 mm column with a Phenomenex(R) C(8) 4 x 10 mm I.D. guard column, and a mobile phase consisting of acetonitrile:water:perchloric acid (HClO(4)) (26:74:0.25) adjusted to pH 2.5 with 5 M sodium hydroxide, a flow-rate of 1.0 ml/min and ultraviolet detection at 350 nm. Correlation coefficients for calibration curves within the detection range of 3-60 microl/ml were 0.9990 for doxycycline and 1.000 and 0.9994 for 6-epidoxycycline and metacycline, respectively (within the range 0.5-7 microl/ml). The resolution between metacycline and 6-epidoxycycline was 1.2 and between 6-epidoxycycline and doxycycline it was 1.9 which fulfils European Pharmacopoeia requirements. The within- and between-day precision was determined for both retention time and peak area. Preliminary results indicate that this method can also be applied for separating other tetracyclines such as minocycline, chlortetracycline, tetracycline and demeclocycline.
This article was published in J Pharm Biomed Anal and referenced in Journal of Bioequivalence & Bioavailability

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version